Exhibit 99.1
Press Release | |
www.shire.com | |
Director/PDMR Shareholding
March 6, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces it was notified today that on March 5, 2014, Phil Vickers, a Person Discharging Managerial Responsibility, sold 1,151 American Depositary Shares in the Company (“ADSs”) at an average sale price of $169.3135. The ADSs were sold on the NASDAQ Global Select Market. One ADS is equal to three Ordinary Shares.
This notification is to satisfy the Company’s obligations under 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.
Tony Guthrie
Deputy Company Secretary
For further information please contact:
Investor Relations | | |
Laurie Stelzer | lstelzer@shire.com | +1 781 482 0733 |
Eric Rojas | erojas@shire.com | +1 781 482 0999 |
Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX